Severity of Flu Season Was High for Children, Teens in 2022 to 2023

FRIDAY, Oct. 13, 2023 (HealthDay News) -- For children and adolescents, the 2022 to 2023 influenza season had high severity, according to research published in the Oct. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Elizabeth B. White, Ph.D., from the CDC in Atlanta, and colleagues describe the 2022 to 2023 influenza season among children and adolescents aged younger than 18 years, including seasonal severity.
The researchers found that compared with thresholds based on previous seasons' influenza-associated outpatient visits, hospitalization rates, and deaths, the 2022 to 2023 influenza season had high severity among children and adolescents. Compared with previous seasons, the incidences of influenza-associated outpatient visits and hospitalization for the 2022 to 2023 season were similar for children aged younger than 5 years and higher for those aged 5 to 17 years. Late November and early December saw peak influenza-associated outpatient and hospitalization activity. Compared with the previous season, a lower proportion of children and adolescents hospitalized with influenza during the 2022 to 2023 season in hospitals participating in the Influenza Hospitalization Surveillance Network were vaccinated (18.3 versus 35.8 to 41.8 percent). Receipt of influenza antiviral treatment was lower among symptomatic hospitalized patients than during pre-COVID-19-pandemic seasons (64.9 versus 80.8 to 87.1 percent).
"The 2022-23 influenza season was classified as high severity for children and adolescents based on influenza-associated outpatient visits, hospitalization rates, and deaths," the authors write. "All persons aged ≥6 months are recommended by CDC to receive the annual seasonal influenza vaccine, ideally by the end of October."
Related Posts
Los frágiles egos masculinos hacen que muchas mujeres ‘finjan’ en la cama
MIÉRCOLES, 2 de febrero de 2022 (HealthDay News) -- Tres nuevos estudios están...
El plan de California de producir insulina de bajo precio podría ser un ejemplo para el país
MIÉRCOLES, 16 de noviembre de 2022 (HealthDay News) -- El plan de California de...
Paxlovid Remains Potent Against Omicron COVID Cases
MONDAY, Feb. 13, 2023 (HealthDay News) -- The COVID-19 antiviral treatment...
Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
THURSDAY, March 10, 2022 (HealthDay News) -- During the 2021-2022 season,...